Minimally invasive, catheter-based procedures have revolutionized the treatment of cardiovascular disease, and transcatheter interventions are becoming more commonplace in veterinary medicine. Transcatheter procedures allow for treatment of several cardiac defects without the attendant morbidity and mortality associated with thoracic surgery. Interventional procedures are available for treatment of patent ductus arteriosus, pulmonic stenosis, atrioventricular valve stenoses, vascular stenoses, atrial and ventricular septal defects, heartworm disease, and certain cardiac arrhythmias. While these interventional procedures are not necessarily less expensive than conventional surgery, these approaches can considerably reduce morbidity and mortality.
for use in human patients and a canine-specific device, the Amplatz Canine Duct Occluder, is commercially available and seems to be the best device for dogs > about 8 lbs. body weight.
Pulmonic stenosis: is common in dogs, but rare in cats. The stenosis may occur at the subvalvular, valvular or supravalvular locations. Valvular stenosis, characterized by dysplastic pulmonary valve leaflets that are thickened, fused and immobile, is the most common manifestation of the disease and is also the most amenable to balloon valvuloplasty. Dogs with pulmonic stenosis typically exhibit a loud systolic ejection murmur at the left heart base and right ventricular (RV) hypertrophy. Disease severity is gauged by the Doppler echo-derived pressure gradient across the pulmonic valve, in combination with the degree of RV hypertrophy, right atrial enlargement, tricuspid valve regurgitation, and the presence or absence of either cardiac arrhythmias or clinical signs. Dogs with the above findings and Doppler gradients across the pulmonic valve of >100 mm Hg are likely to manifest signs of right-sided CHF, arrhythmias, syncope or sudden death. Balloon valvuloplasty is the current treatment of choice in these dogs to prevent or ameliorate clinical signs.
Pulmonic balloon valvuloplasty entails inflation of a balloon dilation catheter engaged within the pulmonary annulus at the level of stenosis. The balloon size is selected to be 1.2 to 1.5 times the diameter of the pulmonary annulus, or the approximate diameter of the normal aortic annulus. In some cases a double balloon procedure, using two smaller balloon catheters, may be more effective. The best candidates for valvuloplasty are those dogs with dysplastic pulmonary valve leaflets (valvular pulmonic stenosis) and a normal pulmonary annulus size. Dogs with a fibrous subvalvular ring and those with concurrent hypoplasia of the pulmonary annulus, and Bulldogs or Boxers with an abnormal coronary artery (R2A coronary anomaly) are at higher risk for complications. Up to 20% of dogs with pulmonic stenosis may have a concurrent atrial septal defect, which can result in hypoxemia due to increased right-to-left shunting during balloon valvuloplasty. In order to identify these potential complicating lesions, cardiac and coronary anatomy should be carefully scrutinized by echocardiography and/or selective angiography prior to balloon valvuloplasty. The overall reported success rate of the procedure exceeds 90%, with sustained clinical improvement in 80% of previously symptomatic dogs.
Subaortic Stenosis: aortic stenosis, typically a result of subvalvular obstruction secondary to a ridge of fibrous tissue, is common in the dog. Typical clinical findings include a loud systolic ejection-quality murmur heard well at the left and right heart base and weak arterial pulses in a large breed dog. Stenosis results in concentric LV hypertrophy and can lead to focal fibrosis of the papillary muscles and subendocardium, a consequence of tissue hypoxia and ischemia. This substrate can lead to ventricular arrhythmias and sudden death in severely affected dogs (transvalvular aortic gradient > 80 to 100 mm Hg). Balloon valvuloplasty is less successful in the treatment of aortic stenosis compared to pulmonic stenosis, although an immediate reduction in the aortic outflow gradient can be seen in many dogs. The author is most inclined to try balloon procedures, typically a double balloon procedure, in dogs with discrete subvalvular ring, those with a valvular component to the stenosis, those less than 6 months of age, and those with overt clinical signs (e.g., syncope). Many cardiologists routinely administer atenolol to affected dogs, but this is a disease with a discrete anatomical limitation, and drug therapy can only do so much. Balloon dilation of the aortic valve is associated with greater risk and more serious arrhythmia than that encountered during pulmonic balloon valvuloplasty.
Atrial septal defects (ASD): are relatively uncommon, but they can be an isolated and problematic defect in Standard Poodles, Boxers, Dobermans and Samoyeds. Though small ASD may be hemodynamically insignificant, large left-to-right shunting defects may result in right atrial and ventricular enlargement, pulmonary hypertension, increased right atrial filling pressures, and the eventual development of right-sided CHF. Successful transcatheter closure of secundum ASDs has been reported in the dog using a self-expanding double-disk septal occluder device. Transthoracic and transesophageal echocardiographic assessment of ASD anatomy are crucial in determining the size and location of the defect and ensuring that there is a sufficient rim of interatrial septal tissue to support the device while avoiding interference with surrounding cardiac structures.
Ventricular septal defects (VSD):
are common in the cat and a predilection for VSD has been described in the English Springer spaniel, Keeshond and English bulldog. Ventricular septal defects are associated with a loud systolic heart murmur, often most prominent on the right chest wall at the right cranial sternal border. The degree of cardiomegaly and pulmonary overcirculation accompanying VSD depends upon the size of the defect and the pulmonary pressures, with small VSDs being hemodynamically unimportant and large defects resulting in pulmonary vascular damage and/or left-sided CHF. Surgical palliation of large VSD may include correction of the defect under cardiopulmonary bypass or circumferential banding of the main pulmonary artery to reduce the volume of left-to-right shunting.
Transcatheter occlusion of suitable defects has been described in the dog, but most VSD are too high in the IVS to allow catheter-based closure techniques with currently available devices.
Tricuspid and Mitral Stenosis: tricuspid stenosis is an uncommon congenital defect characterized by a diastolic pressure gradient between the right atrium and ventricle, right atrial enlargement, atrial arrhythmias and eventual right-sided congestive heart failure. Tricuspid valve stenosis typically accompanies tricuspid dysplasia, a heritable disorder in the Labrador retriever. In the absence of concurrent valvular insufficiency, affected dogs often have soft or absent cardiac murmurs and the disease may go unnoticed until clinical signs develop. Percutaneous balloon valvuloplasty of the tricuspid valve with a single or double balloon procedure may be accomplished by jugular or femoral venous access and valvuloplasty may result in a significant reduction in the pressure gradient across the valve, with attendant improvements in hemodynamics and clinical signs.
Mitral valve dysplasia and stenosis (MS) is an uncommon congenital defect with breed predilections in the Newfoundland and Bull Terrier. Affected dogs typically exhibit signs of exercise intolerance, syncope and congestive heart failure. Percutaneous mitral valvuloplasty is the treatment of choice for human patients with symptomatic MS. This procedure is more difficult to accomplish than other valvuloplasties due to the need for transseptal puncture to access the left atrium. Valvular and supravalvular mitral stenosis have also been described in the cat.
Congenital and Acquired Caval Stenosis:
Vena caval stenosis or stricture formation may occur as a congenital defect or may be acquired secondary to endothelial injury from cardiovascular devices or from cardiac masses. The consequences of caval stenosis depend on the location and severity of the stenosis (cranial cava or caudal cava), and percutaneous treatment of symptomatic stenoses may be achieved with balloon angioplasty or intravascular stenting.
Stenosis of the caudal vena cava (Budd-Chiari-like syndrome) causes hepatomegaly, hepatic venous congestion, and often intractable ascites. Narrowing of the cranial cava results in cranial vena caval syndrome, manifest as jugular distension without pulsation, head and neck edema, sometimes pleural effusion, and depressed mentation. Successful balloon venoplasty and/or stent placement can eliminate clinical signs, sometimes for long periods of time, even in dogs with large obstructive masses. .
Supraventricular Tachycardia Associated with Accessory Pathways:
accessory atrioventricular (AV) conduction pathways, or bypass tracts, are recognized in dogs, cats and horses, although they more commonly cause clinical signs in dogs, especially Labrador Retrievers, Boxers, and other large breed dogs. The abnormal electrical communications across the fibrous cardiac skeleton that normally serves to electrically isolate the atria and ventricles allows for early activation of the ventricles (pre-excitation) and the accessory pathway may function as one limb of a rapid, narrow complex tachyarrhythmia circuit (orthodromic atrioventricular reciprocating tachycardia, or OAVRT). Antiarrhythmic drug strategies are often ineffective for long term management, and recurrent, prolonged tachycardia results in reduced cardiac output and eventually results in tachycardia-induced cardiomyopathy and congestive heart failure. Radiofrequency catheter ablation utilizes an alternating electrical current to induce thermal damage to the accessory pathway and is the standard of care for human patients with macroreentrant tachycardias. The procedure is also highly effective for eliminating accessory pathway conduction in the dog (Wright 2006) however it is only performed in a limited number of specialized centers due to the need for highly specialized equipment and expertise.
Bradyarrhythmias and Cardiac Pacing: high degree second-degree and third-degree atrioventricular (AV) block are associated with signs of exercise intolerance, syncope, cardiac enlargement, and a high incidence of sudden cardiac death. Pacemaker therapy is the only treatment effective in alleviating clinical signs and prolonging survival in affected dogs, and pacemaker implantation is the current standard of care for patients with high grade AV block, atrial standstill, and sick sinus syndrome. Epicardial pacing is still performed in cats and smaller mammals, but transvenous endocardial pacing is the preferred approach in dogs and horses. Permanent transvenous cardiac pacing can be achieved using a wide variety of pacing modalities. Single-chamber permanent transvenous pacing is used most frequently in the dog and is achieved by passing the leadwire through the jugular vein and advancing the lead through the right atrium and into the right ventricle. Most pacemaker lead systems now allow for active fixation of an endocardial lead in the right ventricular myocardium, reducing the chance for leadwire dislodgement. The pulse generator is implanted beneath the skin, and the pacing mode and rate, amplitude and pulse width of the pacing stimulus, and a variety of other features can be subsequently adjusted via an external computer programmer. Variations on this theme include use of a different vein, use of more than 1 leadwire, single chamber or dual chamber pacing, rateresponsive features, and approaches that permit more physiologic pacing via use of specialized leads for the coronary sinus. Complication rate are fairly low (10-20%) and can include lead fracture or dislodgement, infection, battery failure or development of congestive signs in patients with associated structural cardiac disease. The majority of dogs do well and never have recurrence of clinical signs related to the cardiac bradyarrhythmia, with typical survival in excess of 2 years.
Additional Interventional Procedures: other minimally invasive approaches are currently used for the treatment of acquired cardiovascular disease in small animals. These include transjugular heartworm removal for patients with advanced heartworm disease, catheter placement for local thrombolytic therapy, thrombectomy, endomyocardial biopsy, and pulmonary artery catheterization for measurement of cardiac output and pulmonary capillary wedge pressures. Interventional cardiology is developing rapidly and newer minimally invasive approaches will undoubtedly increase the applications in the future.
